Apogee Therapeutics, Inc. - Common Stock (APGE)
41.33
+0.85 (2.10%)
Apogee Therapeutics, Inc. is a biotechnology company focused on developing innovative therapeutic solutions for a range of diseases by harnessing the power of immune system modulation
The company specializes in creating treatments that aim to effectively address conditions that involve dysregulated immune responses. Through its advanced research and development efforts, Apogee Therapeutics is dedicated to improving the lives of patients by providing targeted therapies that can enhance treatment outcomes and reduce the burden of chronic illnesses.
Frequently Asked Questions
Is Apogee Therapeutics, Inc. - Common Stock publicly traded?
Yes, Apogee Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Apogee Therapeutics, Inc. - Common Stock trade on?
Apogee Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Apogee Therapeutics, Inc. - Common Stock?
The ticker symbol for Apogee Therapeutics, Inc. - Common Stock is APGE on the Nasdaq Stock Market
What is the current price of Apogee Therapeutics, Inc. - Common Stock?
The current price of Apogee Therapeutics, Inc. - Common Stock is 41.33
When was Apogee Therapeutics, Inc. - Common Stock last traded?
The last trade of Apogee Therapeutics, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025